Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1388319/000118518519000653/usstem20190331_10q.htm
March 2022
May 2020
March 2020
October 2019
October 2019
September 2019
September 2019
June 2019
June 2019
June 2019
Document And Entity Information - shares | 3 Months Ended | |
---|---|---|
Mar. 31, 2019 | May 07, 2019 | |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | U.S. STEM CELL, INC. | |
Trading Symbol | usrm | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --12-31 | |
Entity Common Stock, Shares Outstanding | 393,694,820 | |
Amendment Flag | false | |
Entity Central Index Key | 0001388319 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Document Period End Date | Mar. 31, 2019 | |
Document Fiscal Year Focus | 2019 | |
Document Fiscal Period Focus | Q1 | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Ex Transition Period | false |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1388319/000118518519000653/usstem20190331_10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by U.S. Stem Cell, Inc..
U.S. Stem Cell, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
U.S. Stem Cell, Inc. provided additional information to their SEC Filing as exhibits
Ticker: USRM
CIK: 1388319
Form Type: 10-Q Quarterly Report
Accession Number: 0001185185-19-000653
Submitted to the SEC: Tue May 07 2019 4:03:40 PM EST
Accepted by the SEC: Tue May 07 2019
Period: Sunday, March 31, 2019
Industry: Commercial Physical And Biological Research